Financial News

Ngm Biopharmaceuticals Inc (NQ: NGM )

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 4, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ngm Biopharmaceuticals Inc

< Previous 1 2 3 4 5 Next >

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NGM Biopharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 27, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Exposures Financial Legal

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NGM Biopharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 25, 2021

From The Schall Law Firm

Via Business Wire

Why NGM Biopharmaceuticals Dived by 41% on Monday

May 24, 2021

The results of a hepatitis drug candidate's clinical trial were not good.

Via The Motley Fool

52 Biggest Movers From Yesterday

May 25, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...

Via Benzinga

Exposures Product Safety

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NGM Biopharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 24, 2021

From The Schall Law Firm

Via Business Wire

Analyst Reactions on NGM Biopharmaceuticals Disappointing Aldafermin Data in NASH Study

May 24, 2021

Today, NGM Biopharmaceuticals Inc (NASDAQ: NGM) reported disappointing results from the Phase 3 trial of aldafermin in NASH patients. What Happened: The...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 250 Points; Scopus BioPharma Shares Spike Higher

May 24, 2021

Toward the end of trading Monday, the Dow traded up 0.75% to 34,462.98 while the NASDAQ rose 1.64% to 13,691.64. The S&P also rose, gaining 1.25% to 4,207.76. The U.S. has the...

Via Benzinga

Topics Stocks

Exposures US Equities

Why Scopus, NGM Biopharma and Taiwan Liposome Are Moving Today

May 24, 2021

Scopus BioPharma Inc. (NASDAQ: SCPS), NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) and Taiwan Liposome Company, Ltd. (NASDAQ: TLC) are among the biggest biopharma movers Monday....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

May 24, 2021

Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2.5%; NGM Biopharmaceuticals Shares Plunge

May 24, 2021

Midway through trading Monday, the Dow traded up 0.58% to 34,405.22 while the NASDAQ rose 1.43% to 13,663.92. The S&P also rose, gaining 1.04% to 4,199.05. The U.S. has the...

Via Benzinga

Topics Stocks

Exposures Fossil Fuels US Equities

35 Stocks Moving In Monday's Mid-Day Session

May 24, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 123.7% to $13.33 after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive...

Via Benzinga

Exposures Product Safety

Mid-Morning Market Update: Markets Open Higher; Xeris Pharmaceuticals To Acquire Strongbridge Biopharma

May 24, 2021

Following the market opening Monday, the Dow traded up 0.50% to 34,378.59 while the NASDAQ rose 1.18% to 13,629.81. The S&P also rose, gaining 0.83% to 4,190.35. The U.S. has...

Via Benzinga

Topics Stocks

Exposures US Equities

NGM Stock Crashes As NASH Drug Joins Gilead, Genfit With Notable Flops

May 24, 2021

NGM Biopharmaceuticals joined a raft of biotech companies with a failed hepatitis treatment on Monday, leading NGM stock to crash.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session

May 24, 2021

Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

NGM Stock Tumbles After Aldafermin Flunks In Mid-Stage NASH Study

May 24, 2021

NGM Biopharmaceuticals Inc (NASDAQ: NGM) has reported results from the 24-week Phase 2b ALPINE 2/3 study evaluating aldafermin in non-alcoholic steatohepatitis (...

Via Benzinga

NGM Biopharma to Release Mid-Stage NASH Data Monday: What to Expect?

May 24, 2021

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is a clinical-stage biopharma developing liver and metabolic disorders therapies. Its stock is down just 6.2% year-to-date...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Ngm Biopharmaceuticals Inc (NQ: NGM )

All News about Ngm Biopharmaceuticals Inc

Popular Pages